BioSyent (RX) Stock Chart & Stock Price History C$11.40 +0.07 (+0.62%) As of 08/15/2025 03:30 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock BioSyent Stock Price Performance The BioSyent (RX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 14.11%, with a year-to-date return of 3.64%. In the past month, the stock has decreased 0.09%, reflecting recent market activity. As of the latest close, BioSyent traded at C$11.40 with a market cap of C$130.39 million and volume of 2,857 shares. Receive RX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-0.09%3 Month Performance-2.98%Year-To-Date Performance+3.64%1 Year Performance+14.11% RX Stock Chart for Saturday, August, 16, 2025 RX Chart by TradingView BioSyent Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025C$11.33C$11.40+0.62%C$11.40C$11.302,857 shsC$130.39 million08/14/2025C$11.40C$11.33-0.61%C$11.35C$11.321,300 shsC$129.59 million08/13/2025C$11.40C$11.40C$11.40C$11.40158 shsC$130.39 million08/12/2025C$11.40C$11.40C$11.45C$11.402,603 shsC$130.39 million08/11/2025C$11.40C$11.40C$11.50C$11.404,130 shsC$130.39 million08/08/2025C$11.45C$11.40-0.44%C$11.40C$11.38634 shsC$130.39 million08/07/2025C$11.45C$11.45C$11.60C$11.454,500 shsC$130.96 million08/06/2025C$11.45C$11.45C$11.45C$11.352,225 shsC$130.96 million08/05/2025C$11.38C$11.45+0.62%C$11.45C$11.352,225 shsC$130.96 million08/04/2025C$11.38C$11.38C$11.38C$11.328,476 shsC$130.16 million Get the Latest News and Ratings for RX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025C$11.31C$11.38+0.62%C$11.38C$11.328,476 shsC$130.16 million07/31/2025C$11.15C$11.31+1.43%C$11.35C$11.202,180 shsC$129.36 million07/30/2025C$11.59C$11.15-3.80%C$11.65C$11.109,844 shsC$127.53 million07/29/2025C$11.68C$11.59-0.77%C$11.59C$11.59305 shsC$132.56 million07/28/2025C$11.68C$11.68C$11.68C$11.68143 shsC$133.59 million07/25/2025C$11.44C$11.68+2.10%C$11.68C$11.68143 shsC$133.59 million07/24/2025C$11.55C$11.44-0.95%C$11.57C$11.441,120 shsC$130.84 million07/23/2025C$11.40C$11.55+1.32%C$11.55C$11.502,300 shsC$132.10 million07/22/2025C$11.40C$11.40C$11.61C$11.401,231 shsC$130.39 million07/21/2025C$11.45C$11.40-0.44%C$11.61C$11.401,231 shsC$130.39 million07/18/2025C$11.40C$11.45+0.44%C$11.55C$11.455,392 shsC$130.96 million07/17/2025C$11.41C$11.40-0.09%C$11.50C$11.354,403 shsC$130.39 million07/16/2025C$11.60C$11.41-1.64%C$11.60C$11.416,100 shsC$130.50 million07/15/2025C$11.65C$11.60-0.43%C$11.68C$11.604,070 shsC$132.67 million Related Companies Aurora Cannabis Stock Price Chart Organigram Stock Price Chart Canopy Growth Stock Price Chart Cipher Pharmaceuticals Stock Price Chart Cardiol Therapeutics Stock Price Chart HLS Therapeutics Stock Price Chart SugarBud Craft Growers Stock Price Chart Medexus Pharmaceuticals Stock Price Chart Decibel Cannabis Stock Price Chart MediPharm Labs Stock Price Chart Receive RX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:RX) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Debt Crisis Is Coming—Will You Be Ready?A full-blown "economic heart attack" is coming—and the markets aren't ready. The problem? Exploding U.S. de...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSyent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access